Ftse Mib
34.640,90
0,52%
DAX
18.758,64
0,41%
S&P 500
5.307,01
0,00%
NASDAQ
16.801,54
0,00%
Bitcoin
69.747,18
0,93%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GeoVax Labs Inc (GOVXW) GeoVax Labs Inc (GOVXW) Notizie

GeoVax Labs Inc

GOVXW
0,04
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:53:21
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/5/202423:23EDGAR2Form 8-K - Current report
21/5/202418:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/5/202422:03EDGAR2Form 8-K - Current report
14/5/202423:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202423:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202423:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/4/202418:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/3/202414:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/3/202414:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
06/3/202415:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
29/2/202422:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
22/2/202415:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
19/2/202415:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
13/2/202415:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
06/2/202415:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
29/1/202415:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
08/1/202415:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
04/1/202415:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
03/1/202415:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
27/12/202315:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
19/12/202315:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
30/11/202322:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
29/11/202315:00GLOBEGeoVax to Participate in Upcoming December Investor Events
28/11/202315:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
14/11/202315:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
08/11/202322:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
31/10/202314:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
30/10/202314:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
25/10/202315:00GLOBEGeoVax to Participate in Upcoming November Investor and..
24/10/202315:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
09/10/202315:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
05/10/202315:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
27/9/202315:00GLOBEGeoVax to Participate in Upcoming October Investor and..
26/9/202315:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
20/9/202315:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
19/9/202315:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
12/9/202315:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
11/9/202315:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
31/8/202315:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
28/8/202315:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
10/8/202315:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
09/8/202322:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
26/7/202315:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
24/7/202315:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
20/7/202315:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
10/7/202315:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..
28/6/202315:00GLOBEGeoVax Announces Gedeptin® Presentation at the AACR-AHNS..
27/6/202316:15GLOBEGeoVax Universal Coronavirus Vaccine Design & Development..
Apertura: Min: Max:
Chiusura: 0,04

La tua Cronologia

NASDAQ
GOVXW
GeoVax Labs
COIN
ALIIIEUR
COIN
COOPGBP
Cooperative Exchange Token
EU
BNEWG
Euronext BeNe 40 Equal W...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network